We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+26.22%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$246B
AUM Growth
+$40.4B
(+20%)
Cap. Flow
-$3.46B
Cap. Flow
% of AUM
-1.41%
Top 10 Holdings %
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$613M |
| 2 |
Match Group
MTCH
|
+$518M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
RTX Corp
RTX
|
+$456M |
| 5 |
Eli Lilly
LLY
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$828M |
| 2 |
Microsoft
MSFT
|
+$510M |
| 3 |
Gilead Sciences
GILD
|
+$465M |
| 4 |
Merck
MRK
|
+$376M |
| 5 |
Walmart Inc
WMT
|
+$369M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.64% |
| 2 | Healthcare | 14.1% |
| 3 | Financials | 12.4% |
| 4 | Consumer Discretionary | 12.19% |
| 5 | Communication Services | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2051
ADT
ADT
$5.58B
| $3.77M | ﹤0.01% |
473,097
-387,142
| -45% | -$2.5M |
|
2052
Vericel Corp
VCEL
$2.31B
| $3.77M | ﹤0.01% |
273,145
-510,598
| -65% | -$6.91M |
|
2053
Prothena Corp
PRTA
$450M
| $3.77M | ﹤0.01% |
360,771
-151,535
| -30% | -$1.68M |
|
2054
Pilgrim's Pride
PPC
$6.54B
| $3.77M | ﹤0.01% |
223,050
+82,691
| +59% | +$1.61M |
|
2055
Madrigal Pharmaceuticals
MDGL
$11.8B
| $3.75M | ﹤0.01% |
33,131
-2,721
| -8% | -$268K |
|
2056
National Healthcare
NHC
$3.38B
| $3.75M | ﹤0.01% |
59,164
+3,725
| +7% | +$250K |
|
|
RPT
2057
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
| $3.75M | ﹤0.01% |
539,239
-910,142
| -63% | -$5.8M |
|
2058
Nelnet
NNI
$4.7B
| $3.74M | ﹤0.01% |
78,288
-44
| -0.1% | -$2.06K |
|
|
EFC
2059
Ellington Financial
EFC
$1.71B
| $3.73M | ﹤0.01% |
316,752
-81,217
| -20% | -$824K |
|
2060
Myriad Genetics
MYGN
$312M
| $3.73M | ﹤0.01% |
328,876
+30,677
| +10% | +$436K |
|
2061
Vitamin Cottage Natural Grocers
NGVC
$654M
| $3.72M | ﹤0.01% |
249,953
-49,137
| -16% | -$598K |
|
|
WDR
2062
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $3.68M | ﹤0.01% |
237,332
-12,834
| -5% | -$176K |
|
|
NREF
2063
NexPoint Real Estate Finance
NREF
$342M
| $3.67M | ﹤0.01% |
219,273
-111,432
| -34% | -$1.48M |
|
2064
Weis Markets
WMK
$1.86B
| $3.66M | ﹤0.01% |
73,002
+1,963
| +3% | +$98.5K |
|
2065
Seagate
STX
$184B
| $3.66M | ﹤0.01% |
75,532
+9,221
| +14% | +$463K |
|
|
SWTX
2066
DELISTED
SpringWorks Therapeutics
SWTX
| $3.66M | ﹤0.01% |
87,075
+44,333
| +104% | +$1.58M |
|
2067
iShares MSCI South Korea ETF
EWY
$25.7B
| $3.65M | ﹤0.01% |
63,917
-111,667
| -64% | -$5.89M |
|
|
DCPH
2068
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $3.64M | ﹤0.01% |
182,420
+77,103
| +73% | +$4.12M |
|
|
HEES
2069
DELISTED
H&E Equipment Services
HEES
| $3.64M | ﹤0.01% |
196,855
+155
| +0.1% | +$2.47K |
|
|
OIBR.C
2070
DELISTED
OI S.A. American Depositary Shares, each representing five shares of common stock
OIBR.C
| $3.62M | ﹤0.01% |
3,451,191
+54,859
| +2% | +$35.7K |
|
2071
Winmark
WINA
$1.32B
| $3.62M | ﹤0.01% |
21,136
+8,124
| +62% | +$1.19M |
|
2072
NRC Health Common Stock
NRC
$450M
| $3.61M | ﹤0.01% |
62,016
+11,012
| +22% | +$582K |
|
2073
Groupon
GRPN
$1.02B
| $3.61M | ﹤0.01% |
199,028
-482,837
| -71% | -$10.7M |
|
2074
Usana Health Sciences
USNA
$286M
| $3.6M | ﹤0.01% |
48,956
-3,360
| -6% | -$264K |
|
2075
United Parks & Resorts
PRKS
$2.12B
| $3.59M | ﹤0.01% |
242,544
+13,155
| +6% | +$194K |
|
Similar funds
VFT
Nuveen's Q2 2020 Portfolio in Review
As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
- Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
- Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
- Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
- Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
- Nuveen opened 266 new positions and closed 200 in Q2 2020.
- Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.
Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.